These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1645707)

  • 21. Measles virus persistent infection: modification of the virus nucleocapsid protein.
    Boriskin YuS ; Bogomolova NN; Koptyaeva IB; Giraudon P; Wild TF
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1979-85. PubMed ID: 3746256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Replication of measles virus in human monocytes and T cells.
    Vydelingum S; Suryanarayana K; Marusyk RG; Salmi AA
    Can J Microbiol; 1995 Jul; 41(7):620-3. PubMed ID: 7641144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of measles virus antigens in acutely and persistently infected cells using monoclonal antibodies: differences in the accumulation of certain viral proteins.
    Giraudon P; Gerald C; Wild TF
    Intervirology; 1984; 21(2):110-20. PubMed ID: 6698760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of papaverine treatment on replication of measles virus in human neural and nonneural cells.
    Yoshikawa Y; Yamanouchi K
    J Virol; 1984 May; 50(2):489-96. PubMed ID: 6708172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation of measles virus nucleoprotein affects viral growth by changing gene expression and genomic RNA stability.
    Sugai A; Sato H; Yoneda M; Kai C
    J Virol; 2013 Nov; 87(21):11684-92. PubMed ID: 23966404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.
    Hasegawa K; Pham L; O'Connor MK; Federspiel MJ; Russell SJ; Peng KW
    Clin Cancer Res; 2006 Mar; 12(6):1868-75. PubMed ID: 16551872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. V and C proteins of measles virus function as virulence factors in vivo.
    Patterson JB; Thomas D; Lewicki H; Billeter MA; Oldstone MB
    Virology; 2000 Feb; 267(1):80-9. PubMed ID: 10648185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of papaverine on HVJ (Sendai virus) replication in rat glioma C6 cells.
    Ogura H; Sato H; Hatano M
    J Gen Virol; 1987 Apr; 68 ( Pt 4)():1143-52. PubMed ID: 3033129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anesthetic action and virus replication: inhibition of measles virus replication in cells exposed to halothane.
    Knight PR; Nahrwold ML; Bedows E
    Antimicrob Agents Chemother; 1980 May; 17(5):890-6. PubMed ID: 6156646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of measles virus replication by 5'-nor carbocyclic adenosine analogues.
    Barnard DL; Stowell VD; Seley KL; Hegde VR; Das SR; Rajappan VP; Schneller SW; Smee DF; Sidwell RW
    Antivir Chem Chemother; 2001 Jul; 12(4):241-50. PubMed ID: 11771733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inefficient measles virus budding in murine L.CD46 fibroblasts.
    Vincent S; Spehner D; Manié S; Delorme R; Drillien R; Gerlier D
    Virology; 1999 Dec; 265(2):185-95. PubMed ID: 10600591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of human complement regulatory protein CD46 restricts measles virus replication in mouse macrophages.
    Korte-Sarfaty J; Pham VD; Yant S; Hirano A; Wong TC
    Biochem Biophys Res Commun; 1998 Aug; 249(2):432-7. PubMed ID: 9712714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The measles virus replication cycle.
    Rima BK; Duprex WP
    Curr Top Microbiol Immunol; 2009; 329():77-102. PubMed ID: 19198563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced intranuclear expression of measles virus following exposure of persistently infected cells to cyclic AMP.
    Robbins SJ; Eagle JP
    J Gen Virol; 1985 Sep; 66 ( Pt 9)():2065-70. PubMed ID: 2993491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical measles after measles virus challenge in simian immunodeficiency virus-infected measles virus-vaccinated rhesus monkeys.
    Permar SR; Rao SS; Sun Y; Bao S; Buzby AP; Kang HH; Letvin NL
    J Infect Dis; 2007 Dec; 196(12):1784-93. PubMed ID: 18190259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonpeptide inhibitors of measles virus entry.
    Sun A; Prussia A; Zhan W; Murray EE; Doyle J; Cheng LT; Yoon JJ; Radchenko EV; Palyulin VA; Compans RW; Liotta DC; Plemper RK; Snyder JP
    J Med Chem; 2006 Aug; 49(17):5080-92. PubMed ID: 16913698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles virus activates NF-kappa B and STAT transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549.
    Helin E; Vainionpää R; Hyypiä T; Julkunen I; Matikainen S
    Virology; 2001 Nov; 290(1):1-10. PubMed ID: 11882993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a halothane-resistant strain of measles virus.
    Bedows E; Davidson BA; Williams BA; Knight PR
    Antimicrob Agents Chemother; 1989 Mar; 33(3):400-3. PubMed ID: 2658788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation.
    Fujinami RS; Oldstone MB
    J Immunol; 1980 Jul; 125(1):78-85. PubMed ID: 7381212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the virus-host cell relationship in a stable non-virogenic cell line persistently infected with measles virus (BGM/MV).
    May JD; Menna JH
    J Gen Virol; 1979 Oct; 45(1):185-94. PubMed ID: 118238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.